JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Clinical trial NCT07175389 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07175389
Sponsor: West China Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Pancreatic Ductal Adenocarcinoma Refractory Pancreatic Adenocarcinoma

Start date: 2026-09-01
Primary completion: 2028-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.